Anti-SARS-CoV-2 Nucleocapsid Antibody, Human IgG1 (AS95) (MALS verified), Unconjugated 100 mg

Produktübersicht

• Artikelname: Anti-SARS-CoV-2 Nucleocapsid Antibody, Human IgG1 (AS95) (MALS verified), Unconjugated 100 mg
• Artikelnummer: ABS-NUN-CH14-100MG
• Hersteller Artikelnummer: NUN-CH14-100mg
• Alternativnummer: ABS-NUN-CH14-100MG
• Hersteller: AcroBiosystems
• Kategorie: Antikörper
• Spezies Reaktivität: Human
• Konjugation: Unconjugated

Produktbeschreibung

AntiSARSCoV2 Nucleocapsid Antibody, Human IgG1 is isolated from a SARSCoV2 infected patient and is recombinantly produced from CHO cells. This monoclonal antibody is purified by Protein A affinity chromatography. As verified by binding test with NNTD (Cat.No. NUNC5143) and NCTD (Cat.No. NUNC5145) protein, this antibody can only bind to NNTD (AA Gly 44 Glu 174). ELISA test validated that this antibody can bind multiple N protein variants with similar affinity as compared to the wild type N protein (Cat.No. NUNC5227). - Antikörper

Produkteigenschaften

• Tag: Human IgG1 | Human Kappa
• Puffer: PBS, pH7.4
• Reinheit: 0.95
• Formulierung: Liquid
• Target-Kategorie: Nucleocapsid protein

Bilder

Immobilized SARS-CoV-2 (COVID-19) Nucleocapsid protein, His Tag (Cat. No. NUN-C5227) at 2µg/mL (100µL/well) can bind Anti-SARS-CoV-2 Nucleocapsid Antibody, Human IgG1 (AS95) (Cat. No. NUN-CH14) with a linear range of 0.2-6 ng/mL (Routinely tested).

Immobilized Anti-SARS-CoV-2 Nucleocapsid Antibody, Human IgG1 (AS95) (Cat. No. NUN-CH14) at 1µg/mL (100µL/well) can bind SARS-CoV-2 Nucleocapsid protein, His Tag (B.1.1.529/Omicron) (Cat. No. NUN-C52Ht) with a linear range of 0.4-6 ng/mL (Routinely tested).

Anti-SARS-CoV-2 Nucleocapsid Antibody, Human IgG1 (AS95) on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 0.95.